Search Results
Nov 17, 2025, 17:42 ET Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London
blood pumps already in the hospital (e.g. dialysis, continuous renal replacement therapy or CRRT, extracorporeal membrane oxygenation or ECMO, and heart-lung machines), where blood is repeatedly recirculated outside the body, through our cartridges where toxic substances are removed, and then back into the
More news about: Cytosorbents Corp
Nov 17, 2025, 17:31 ET Sepsis Market is Projected to Boost at a CAGR of 5.1% in the US During the Forecast Period (2025-2034) | DelveInsight
develop in anyone, certain groups are more vulnerable. These include older adults over 65, people with chronic illnesses such as diabetes, kidney, lung, or cancer-related conditions, and those with weakened immune systems from medications or HIV/AIDS. Others at elevated risk include recently hospitalized
More news about: DelveInsight Business Research, LLP
Nov 17, 2025, 16:01 ET Nuvalent Announces Public Offering of Common Stock
responses. Nuvalent is advancing a robust pipeline with investigational candidates for ROS1-positive, ALK-positive, and HER2-altered non-small cell lung cancer, and multiple discovery-stage research programs. Cautionary Note Regarding Forward-Looking Statements
More news about: Nuvalent, Inc.
Nov 17, 2025, 13:01 ET Cincinnati Children's accelerating breakthroughs in care for cancer, blood diseases and genetic disorders with new center
disease, which can cause severe pain and organ damage. Additional research focuses on developing treatments for hereditary protein alveolar proteinosis, a lung disease that can cause shortness of breath, a chronic cough and fatigue. Gene and cell therapy products are living, highly complex medicines,
More news about: Cincinnati Children's Hospital Medical Center
Nov 17, 2025, 10:30 ET CT Simulators Market worth US$741.7 million by 2030 with 4.6% CAGR | MarketsandMarkets™
reliable compatibility with treatment planning systems (e.g., Varian Eclipse, Elekta Monaco, RayStation). While 4D CT enables motion management (e.g., lung and liver tumors), it is expensive and resource intensive. 3D CT offers a balance of accuracy, efficiency, and affordability, leading to broader adoption
More news about: MarketsandMarkets
Nov 17, 2025, 08:30 ET Cipla USA Strengthens Lung Leadership with Community Wellness Initiatives
noteworthy leadership in lung health," said Jean Wright, M.D., MBA, CEO of the COPD Foundation. "The company's support helps us meet our mission of helping millions of people live longer and healthier lives by advancing awareness, research and treatments to stop COPD and other lung diseases."
More news about: Cipla USA Inc.
Nov 17, 2025, 08:15 ET Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization
breast cancer and ovarian cancer, as well as additional cancer vaccines to address many intractable cancers, including high incidence malignancies in lung, colon, and prostate. These vaccine technologies focus on immunizing against "retired" proteins that have been found to be expressed in certain forms
More news about: Anixa Biosciences, Inc.
Nov 17, 2025, 06:30 ET Nuvalent Announces Positive Topline Pivotal Data from ALKOVE-1 Clinical Trial of Neladalkib for TKI Pre-treated Patients with Advanced ALK-positive NSCLC
neladalkib, an investigational ALK-selective inhibitor, in tyrosine kinase inhibitor (TKI) pre-treated patients with advanced ALK-positive non-small cell lung cancer (NSCLC) from the global ALKOVE-1 Phase 1/2 clinical trial. Additionally, the company shared the first report of preliminary data from the Phase
More news about: Nuvalent, Inc.
Nov 17, 2025, 06:21 ET Karmanos Cancer Institute Recognizes Lung Cancer Awareness Month, Encourages Screenings
Lung Cancer Facts and Figures About 226,650 new cases of lung cancer will be diagnosed in 2025. The chance that a man will develop lung cancer in his lifetime is about
More news about: Karmanos Cancer Institute
Nov 16, 2025, 04:49 ET Para Pemimpin Asuransi Global Berkumpul di Bangkok: Memperkuat Daya Saing Lewat Fondasi Strategis
profesionalisme, peningkatan kualitas layanan, inovasi, dan kemampuan beradaptasi dalam struktur yang stabil. Dalam sambutannya, Liang Tien Lung, Founding Chairman, CIA500 Summit, menegaskan prinsip utama kepemimpinan: "Jika memiliki visi masa depan yang jelas, maka kita semakin berorientasi
More news about: Chinese Insurance Agency 500 Summit
Nov 14, 2025, 16:30 ET IceCure Medical Announces Receipt of Nasdaq Minimum Bid Price Notification
cryoablation therapy systems for the treatment of tumors (benign and cancerous) by freezing, with the primary focus areas being breast, kidney, bone and lung cancer. Its minimally invasive technology is a safe and effective alternative to hospital surgical tumor removal that is easily performed in a relatively
More news about: IceCure Medical
Nov 14, 2025, 16:01 ET Nuvalent Announces Timing of Topline Pivotal Data for TKI Pre-treated Patients with Advanced ALK-positive NSCLC from ALKOVE-1 Clinical Trial of Neladalkib
topline pivotal data for neladalkib, an investigational ALK-selective inhibitor, in TKI pre-treated patients with advanced ALK-positive non-small cell lung cancer from the global ALKOVE-1 Phase 1/2 clinical trial.
More news about: Nuvalent, Inc.
Nov 14, 2025, 10:31 ET SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Tvardi
clinical trial of TTI-101 in idiopathic pulmonary fibrosis. The study was designed to assess safety, pharmacokinetics, and exploratory outcomes related to lung function. After reviewing the preliminary safety data and exploratory efficacy results, including changes in Forced Vital Capacity (FVC), the Company
More news about: Faruqi & Faruqi, LLP
Nov 13, 2025, 16:05 ET Trevi Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease (non-IPF ILD), and refractory chronic cough (RCC), today announced financial results for the quarter ended September 30, 2025, and provided
More news about: Trevi Therapeutics, Inc.
Nov 13, 2025, 16:05 ET CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update
blood pumps already in the hospital (e.g. dialysis, continuous renal replacement therapy or CRRT, extracorporeal membrane oxygenation or ECMO, and heart-lung machines), where blood is repeatedly recirculated outside the body, through our cartridges where toxic substances are removed, and then back into the
More news about: Cytosorbents Corp
Nov 13, 2025, 15:38 ET OU Health Stephenson Cancer Center Breaks Ground on Major Tulsa Expansion
phasing in clinical trials at Hillcrest and has enrolled more than 20 patients so far this year, including those for complex cancers like pancreatic and lung. "Partnering with OU Health on cancer care has already brought more clinical trials and specialized expertise to northeast Oklahoma,"
More news about: University of Oklahoma
Nov 13, 2025, 11:07 ET Immune Reactions Found Behind Human Rejection of Transplanted Pig Kidneys
ProCure On-Demand; the Spanish Society of Transplantation; the Transplant Society; LiveOnNY; the National Kidney Foundation; Sanofi-Aventis U.S.; and Lung Biotechnology, a subsidiary of United Therapeutics, and PBC BioMed. He has also previously served on the advisory boards for the biotechnology companies
More news about: NYU Grossman School of Medicine and NYU Langone Health
Nov 13, 2025, 09:31 ET November is Lung Cancer Awareness Month: Screening Saves Aims to Increase Access to Lung Screenings in NC
Nov. 13, 2025 /PRNewswire/ -- In recognition of Lung Cancer Awareness Month, the non-profit Lung Cancer Initiative (LCI) is urging high-risk individuals to get screened for lung cancer. Through its Screening
More news about: Lung Cancer Initiative
Nov 13, 2025, 08:00 ET Withings Redefines At-Home Family Healthcare in the US with FDA Clearance of BeamO
stethoscope records heart & lung sounds, plus BeamO's thermometer tracks temperature instantly for all ages, which can be easily shared with a doctor to support better care, and make it easier to monitor symptoms when sickness hits. While BeamO doesn't diagnose, recording lung sounds and temperature over
More news about: Withings
Nov 13, 2025, 07:00 ET Insmed Strengthens Communities Worldwide During Fourth Annual Global Day of Good
greatest. Insmed's most advanced programs are in pulmonary and inflammatory conditions, including two approved therapies to treat chronic, debilitating lung diseases. The Company's early-stage programs encompass a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering,
More news about: Insmed Incorporated
Nov 13, 2025, 07:00 ET Tract Bio Announces Opening of New Laboratory at The Pearl Innovation District
and inflammatory diseases, including chronic myeloid leukemia (CML), multiple myeloma (MM), acute myeloid leukemia (AML), oesophageal adenocarcinoma, lung, pancreatic, ovarian and gastric cancer, as well as chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis, cystic fibrosis and
More news about: Tract Bio
Nov 13, 2025, 03:30 ET Blue Cell Therapeutics appoints leading cell therapy executive Miguel Forte MD, PhD, to its Board of Directors
globally with 30% not responding to drug therapy. In PAH, Blue Cell has successfully shown that BlueC-231 efficiently decreased lung blood pressure in an animal model. This initiates a preclinical programme testing BlueC-231 in addition to standard therapy.
More news about: Blue Cell Therapeutics
Nov 12, 2025, 16:02 ET GRAIL Reports Third Quarter 2025 Financial Results
colorectal, and lung cancers (USPSTF A and B recommendations) led to a more than seven-fold increase in the number of cancers found within a yearGalleri detected approximately three times as many cancers when added to standard-of-care screening for breast, cervical, colorectal, lung, and prostate
More news about: GRAIL, Inc.
Nov 12, 2025, 16:00 ET Fractal Wins Microsoft Partner of The Year 2025
Qure.ai, a global healthcare AI leader enhancing the rapid identification and management of tuberculosis, lung cancer, and stroke. Fractal's dedicated AI research team is focused on foundational AI advancements, including knowledge-based foundational models,
More news about: Fractal Analytics Limited
Nov 12, 2025, 16:00 ET Fractal Wins Microsoft Partner of The Year 2025
Qure.ai, a global healthcare AI leader enhancing the rapid identification and management of tuberculosis, lung cancer, and stroke. Fractal's dedicated AI research team is focused on foundational AI advancements, including knowledge-based foundational models,
More news about: Fractal Analytics Limited